Frequency Therapeutics, Inc. (FREQ)

NASDAQ: FREQ · IEX Real-Time Price · USD
5.14 -0.05 (-0.96%)
Jan 14, 2022 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2020201920182017
Revenue
36.9828.9500
Revenue Growth
27.76%---
Gross Profit
36.9828.9500
Selling, General & Admin
27.1214.847.064.34
Research & Development
37.4218.7811.8811.97
Other Operating Expenses
01600
Operating Expenses
64.5349.6218.9416.31
Operating Income
-27.55-20.68-18.94-16.31
Interest Expense / Income
-0.99-1.780.110.17
Other Expense / Income
-0.08-0.150.123.76
Pretax Income
-26.48-18.75-19.17-20.24
Income Tax
0.04000
Net Income
-26.51-18.75-19.17-20.24
Preferred Dividends
01.0500
Net Income Common
-26.51-19.8-19.17-20.24
Shares Outstanding (Basic)
32921
Shares Outstanding (Diluted)
32921
Shares Change
272.90%465.23%117.70%-
EPS (Basic)
-0.82-2.29-12.53-28.79
EPS (Diluted)
-0.82-2.29-12.53-28.79
Free Cash Flow Per Share
-1.613.83-11.41-23.44
Gross Margin
100.00%100.00%--
Operating Margin
-74.49%-71.42%--
Profit Margin
-71.68%-64.76%--
Free Cash Flow Margin
-140.22%114.53%--
Effective Tax Rate
-0.13%0.00%0.00%0.00%
EBITDA
-25.89-19.72-18.41-19.53
EBITDA Margin
-70.00%-68.11%--
EBIT
-27.47-20.53-19.06-20.06
EBIT Margin
-74.28%-70.92%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).